Junya Fukuoka Selected Research

Junya Fukuoka Research Topics

Disease

56	Neoplasms (Cancer) 02/2024 - 10/2004
19	Lung Neoplasms (Lung Cancer) 09/2023 - 10/2004
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 03/2005
12	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2023 - 07/2005
10	Adenocarcinoma of Lung 11/2021 - 07/2004
10	Adenocarcinoma 11/2021 - 02/2007
10	Carcinoma (Carcinomatosis) 01/2021 - 10/2004
7	Carcinogenesis 09/2023 - 01/2006
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 07/2004
6	Idiopathic Pulmonary Fibrosis 05/2024 - 07/2005
6	Neoplasm Metastasis (Metastasis) 11/2020 - 02/2011
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 07/2011
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 12/2010
4	Thymoma (Thymic Carcinoma) 04/2023 - 01/2020
4	Bronchiectasis 07/2022 - 01/2013
4	Dyspnea (Shortness of Breath) 01/2020 - 01/2013
4	Disease Progression 05/2019 - 12/2010
4	Connective Tissue Diseases (Connective Tissue Disease) 11/2018 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2015 - 10/2004
3	Metaplasia 05/2024 - 07/2005
3	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 07/2012
3	Respiratory Insufficiency (Respiratory Failure) 05/2023 - 12/2010
3	Dermatomyositis (Dermatopolymyositis) 03/2023 - 03/2014
3	Melanoma (Melanoma, Malignant) 03/2023 - 04/2013
3	Fibrosis (Cirrhosis) 01/2022 - 12/2011
3	Hyperplasia 01/2021 - 01/2012
3	Breast Neoplasms (Breast Cancer) 08/2018 - 07/2009
3	Esophageal Squamous Cell Carcinoma 01/2017 - 12/2012
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2022 - 07/2005
2	Lymphoma (Lymphomas) 12/2021 - 01/2015
2	Necrosis 11/2021 - 01/2010
2	Infections 02/2021 - 01/2020
2	Human Influenza (Influenza) 02/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 01/2019
2	Vascular Diseases (Vascular Disease) 01/2020 - 07/2005
2	Cysts 01/2019 - 09/2010
2	Vasculitis (Vasculitides) 01/2018 - 12/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 01/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2017 - 01/2017
2	Lymphatic Metastasis 01/2017 - 04/2013
2	Spontaneous Remission 01/2015 - 12/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2004
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2012
5	Indicators and Reagents (Reagents)IBA 05/2024 - 06/2013
5	Phosphotransferases (Kinase)IBA 02/2021 - 03/2005
5	LigandsIBA 05/2019 - 12/2016
4	AntibodiesIBA 03/2023 - 12/2010
4	AntigensIBA 01/2023 - 06/2012
4	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2004
4	Formaldehyde (Formol)FDA Link 04/2021 - 07/2011
4	pembrolizumabIBA 01/2021 - 12/2018
3	FibrinIBA 05/2024 - 08/2003
3	AutoantibodiesIBA 03/2023 - 12/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 11/2018
3	AcidsIBA 03/2022 - 06/2015
3	S-1 plus cisplatinIBA 01/2022 - 01/2012
3	ParaffinIBA 04/2021 - 07/2011
3	CarcinogensIBA 01/2021 - 10/2017
3	CollagenIBA 01/2020 - 07/2005
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2013
3	NivolumabIBA 12/2018 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 08/2013 - 03/2005
2	Transcription Factors (Transcription Factor)IBA 04/2023 - 04/2018
2	Immunoglobulins (Immunoglobulin)IBA 03/2023 - 02/2012
2	Immunoglobulin G (IgG)IBA 03/2023 - 01/2019
2	HABAIBA 07/2022 - 02/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2022 - 01/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 11/2021
2	Adenosine Triphosphatases (ATPase)IBA 05/2021 - 07/2010
2	CytokinesIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2013
2	PlatinumIBA 01/2021 - 05/2019
2	Immune Checkpoint InhibitorsIBA 05/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 12/2012
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 12/2012
2	Phenobarbital (Luminal)FDA Link 09/2017 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017 - 08/2013
2	MicroRNAs (MicroRNA)IBA 02/2014 - 07/2011
2	Desmoglein 3IBA 09/2013 - 02/2007
2	Keratin-5 (Keratin 5)IBA 09/2013 - 02/2012
2	Tyrosine Kinase InhibitorsIBA 08/2013 - 03/2005
2	Gefitinib (Iressa)FDA Link 08/2013 - 01/2011
2	Gemcitabine FDA Link 07/2013 - 02/2011

Therapy/Procedure

23	Therapeutics 05/2023 - 03/2005
15	Drug Therapy (Chemotherapy) 05/2023 - 04/2007
4	Traction 07/2022 - 01/2013
4	Radiotherapy 01/2022 - 04/2007
3	Immunotherapy 02/2024 - 11/2019
2	Extracorporeal Membrane Oxygenation 05/2023 - 01/2019
2	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 02/2011
2	Chemoradiotherapy 01/2022 - 06/2019
2	Hysterectomy 10/2021 - 09/2010
2	Artificial Respiration (Mechanical Ventilation) 09/2019 - 12/2010
2	Hematopoietic Stem Cell Transplantation 01/2019 - 01/2019
2	Prostatectomy (Retropubic Prostatectomy) 10/2017 - 01/2014
2	Lasers (Laser) 06/2015 - 10/2004